Solensia Frequently Asked Questions
Solensia is administered by veterinary professionals. If you suspect your cat suffers from OA pain, ask your vet health team about Solensia.
In a clinical study, Solensia was shown to be well tolerated by cats—the most common side effects reported were vomiting and injection site pain.
As with all medicines, there are potential side effects. Talk to your veterinarian about the benefits and risks before starting your cat on any treatment.
77% of cat owners reported seeing improvements in signs of pain when their cats were treated monthly with Solensia in a 3-month study.3*
In a study, Solensia was shown to increase mobility in cats after a single treatment.1
*67% of cat owners experienced improvement in signs of their cat’s pain in the placebo group.
As a monthly injection administered at your vet’s office, your vet will schedule an appointment every 4 weeks to administer treatment and reassess your cat's OA pain and mobility.
In one study, improvements in cat owner rating of mobility were seen as early as 14 days compared to placebo.1 As individual results will vary, it's best to talk with your vet health team to hear how Solensia is working in their patients.
Yes. Solensia is safe for cats, and a conversation with your vet is the best way to confirm Solensia is right for your cat. For example, Solensia should not be used in cats who have a sensitivity to the active ingredient, frunevetmab. Solensia also shouldn't be used in cats who are pregnant, breeding, or lactating. The most common side effects that occurred in a clinical study were vomiting and injection site pain.3
Before considering Solensia, it’s always best to tell your vet about all the medications your cat is taking. However, Solensia should not be administered to cats with known allergy to frunevetmab.
Solensia works like your cat’s naturally made antibodies to reduce pain signals.3
No. Solensia is for use in cats only.
Your veterinarian determines the cost of Solensia for your cat.
Solensia is a once-monthly injection safely given to your cat by a veterinary professional.
IMPORTANT SAFETY INFORMATION: For use in cats only. Women who are pregnant, trying to conceive or breastfeeding should take extreme care to avoid self-injection. Allergic reactions, including anaphylaxis, could potentially occur with self-injection. SOLENSIA should not be used in breeding cats or in pregnant or lactating queens. SOLENSIA should not be administered to cats with a known allergy to frunevetmab. The most common adverse events reported in a clinical study were vomiting and injection site pain. Solensia may be associated with scabbing of the head and neck, dermatitis, and pruritus. See full Prescribing Information.
INDICATION: For the control of pain associated with osteoarthritis in cats.
References:
- Gruen ME, Myers JAE, Lascelles BDX. Efficacy and safety of an anti-nerve growth factor antibody (frunevetmab) for the treatment of degenerative joint disease-associated chronic pain in cats: a multisite pilot field study. Front Vet Sci. 2021;8:610028. doi:10.3389/fvets.2021.610028.
- Solensia (frunevetmab injection). Package insert. Zoetis Inc; 2022.
- Keizer RJ, Huitema AD, Schellens JH, Beijnen JH. Clinical pharmacokinetics of therapeutic monoclonal antibodies. Clin Pharmacokinet. 2010;49(8):493-507. doi:10.2165/11531280.
